Marker Therapeutics (MRKR) Asset Utilization Ratio (2016 - 2025)
Marker Therapeutics (MRKR) has disclosed Asset Utilization Ratio for 8 consecutive years, with 0.09 as the latest value for Q3 2025.
- On a quarterly basis, Asset Utilization Ratio fell 121.31% to 0.09 in Q3 2025 year-over-year; TTM through Sep 2025 was 0.09, a 121.31% decrease, with the full-year FY2024 number at 0.01, down 92.05% from a year prior.
- Asset Utilization Ratio was 0.09 for Q3 2025 at Marker Therapeutics, down from 0.06 in the prior quarter.
- In the past five years, Asset Utilization Ratio ranged from a high of 0.44 in Q3 2024 to a low of 0.09 in Q3 2025.
- A 5-year average of 0.11 and a median of 0.08 in 2022 define the central range for Asset Utilization Ratio.
- Peak YoY movement for Asset Utilization Ratio: skyrocketed 933.48% in 2023, then plummeted 125.0% in 2025.
- Marker Therapeutics' Asset Utilization Ratio stood at 0.01 in 2021, then skyrocketed by 1235.06% to 0.09 in 2022, then soared by 94.42% to 0.18 in 2023, then tumbled by 65.39% to 0.06 in 2024, then plummeted by 248.46% to 0.09 in 2025.
- Per Business Quant, the three most recent readings for MRKR's Asset Utilization Ratio are 0.09 (Q3 2025), 0.06 (Q2 2025), and 0.01 (Q1 2025).